DAVID HEATH: Open Payments
NPI 1699130252 · OROSI, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 18 payments from 14 companies in 2025. Trend: 2023 $995 · 2024 $269 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $81 |
| ABBVIE INC. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Teleflex LLC | 1 | $28 |
| Almatica Pharma LLC | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
Products named: JARDIANCE, LINZESS, UROLIFT, ZEPBOUND, LOREEV XR, Kerendia, TRELEGY ELLIPTA, Korlym.
Industry payments across CA — which companies pay providers there.
